Mr. Girglani joined Milestone as Vice President of Marketing in August 2022. Prior to Milestone Pharmaceuticals, he served as the Vice President of U.S. Marketing for Autoimmune and Rare Diseases at Mallinckrodt Pharmaceuticals, where he functioned as the U.S. commercial leader responsible for achieving target forecasted sales and profits for Acthar Gel, which was promoted for nine indications. In this role, Mr. Girglani stabilized and revitalized Acthar Gel in face of severe reimbursement and media challenges. He also built a high-performance marketing team in multiple therapeutic, and diverse HCP specialties. Before joining Mallinckrodt Pharmaceuticals in 2018, Mr. Girglani also held executive-level positions in marketing, new product planning, market access, and sales at Glaxo Smith Kline (GSK), Cardinal Health Specialty, Merck/Schering-Plough, Pharmacia, Sanofi Pharmaceuticals, and Roche Laboratories. He has a passion for serving patient communities and integrating patient support services and digital approaches into high-impact campaigns.
Mr. Girglani received a Bachelor of Commerce and Management degree from the Indian Institute of Management where he graduated in the Honors program. He later obtained an M.B.A. with a focus on Marketing from Eastern Michigan University.
Current role